Akums Drugs and Pharmaceuticals (NSE:AKUMS) Other Current Liabilities: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AKUMS Akums Drugs and Pharmaceuticals Ltd NSE:AKUMS
40 GF Score
Price ₹750.00
! 6 Warning Signs
View Full Analysis

What is Akums Drugs and Pharmaceuticals Other Current Liabilities?

Akums Drugs and Pharmaceuticals NSE:AKUMS -0.39% 40 Other Current Liabilities is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:AKUMS with a GF Score™ of 40/100. The stock has 6 warning signs investors should review.

Akums Drugs and Pharmaceuticals's other current liabilities for the quarter that ended in Jun. 2026 was ₹0 Mil.

Akums Drugs and Pharmaceuticals's quarterly other current liabilities increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹2,718 Mil) but then declined from Mar. 2026 (₹2,718 Mil) to Jun. 2026 (₹0 Mil).

Akums Drugs and Pharmaceuticals's annual other current liabilities declined from Mar. 2024 (₹1,752 Mil) to Mar. 2025 (₹1,455 Mil) but then increased from Mar. 2025 (₹1,455 Mil) to Mar. 2026 (₹2,718 Mil).

Akums Drugs and Pharmaceuticals Other Current Liabilities Related Terms

Akums Drugs and Pharmaceuticals Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Akums Drugs and Pharmaceuticals's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Akums Drugs and Pharmaceuticals Other Current Liabilities Chart

Akums Drugs and Pharmaceuticals Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Liabilities
Get a 7-Day Free Trial 2,758.82 2,010.71 1,752.19 1,454.83 2,718.02

Akums Drugs and Pharmaceuticals Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1,932.62 0.00 2,718.02 0.00
NSE:AKUMS
40GF Score
Akums Drugs and Pharmaceuticals Ltd NSE:AKUMS
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Akums Drugs and Pharmaceuticals Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of ₹0 Mil mean?
Akums Drugs and Pharmaceuticals (NSE:AKUMS) has a Other Current Liabilities of ₹0 Mil as of Jun. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Akums Drugs and Pharmaceuticals.
Is Akums Drugs and Pharmaceuticals' Other Current Liabilities too high?
Akums Drugs and Pharmaceuticals' current Other Current Liabilities is ₹0 Mil. Overall, Akums Drugs and Pharmaceuticals has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Akums Drugs and Pharmaceuticals' Other Current Liabilities compare to ZTS?
Akums Drugs and Pharmaceuticals' Other Current Liabilities of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Akums Drugs and Pharmaceuticals. Akums Drugs and Pharmaceuticals's current Other Current Liabilities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akums Drugs and Pharmaceuticals stock overvalued right now?
Akums Drugs and Pharmaceuticals (NSE:AKUMS) has a current Other Current Liabilities of ₹0 Mil. The current Other Current Liabilities is ₹0 Mil. Akums Drugs and Pharmaceuticals' overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Akums Drugs and Pharmaceuticals (NSE:AKUMS), the current Other Current Liabilities is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Akums Drugs and Pharmaceuticals Business Description

Other Exchanges 544222:India
Address Akums House, Plot No. 131 to 133, Block C, Mangolpuri Industrial Area Phase1, Adjoining CBSE Office, Delhi, IND, 110083
Akums Drugs and Pharmaceuticals Ltd a pharmaceutical contract development and manufacturing organization offering a comprehensive range of pharmaceutical products and services in India and overseas. Its services include formulation research and development (R&D), preparation and filing of regulatory dossiers in the Indian and Outside markets, and other testing services. It is also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs). It operates in five segments: Contract Development and Manufacturing Operations, Active Pharmaceutical Ingredient (API), Domestic Branded formulations, International Branded Formulations, and Trade generics. Key revenue is generated from Contract Development and Manufacturing Operations.
40GF Score

Get the complete analysis for NSE:AKUMS

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹750.00
Price